中华眼底病杂志
中華眼底病雜誌
중화안저병잡지
CHINESE JOURNAL OF OCULAR FUNDUS DISEASES
2009年
1期
38-42
,共5页
安建斌%马景学%高彦军%刘丹岩%盛梦怡%王红霞%刘丽娅
安建斌%馬景學%高彥軍%劉丹巖%盛夢怡%王紅霞%劉麗婭
안건빈%마경학%고언군%류단암%성몽이%왕홍하%류려아
姜黄素/投药和剂量%色素上皮,眼%细胞增殖/药物作用%玻璃体视网膜病,增生性/药物疗法%动物实验
薑黃素/投藥和劑量%色素上皮,眼%細胞增殖/藥物作用%玻璃體視網膜病,增生性/藥物療法%動物實驗
강황소/투약화제량%색소상피,안%세포증식/약물작용%파리체시망막병,증생성/약물요법%동물실험
Curcumin/administration & dosage%Pigment epithelium of eye%Cell proliferation/drug effects%Vitreoretinopathy,proliferative/drug therapy%Animal experimentation
目的 探讨姜黄素对兔视网膜色素上皮(RPE)细胞增生的抑制作用及其作用机制.方法 选取第4代RPE细胞进行实验,分为姜黄素组和空白对照组,姜黄素组设10、15、20 μg/ml 3个质量浓度.噻唑蓝比色(MTT)法检测姜黄素10、15、20μg/ml分别在24、48、72、96 h对体外培养的RPE细胞增生的抑制率.线性回归分析计算各时间段的半数抑制率(IC50)剂量.流式细胞仪(FMC)检测姜黄素15 μg/ml作用72 h后对RPE细胞周期的影响,并且检测姜黄素15μg/ml作用24、48,72 h后RPE细胞增生细胞核抗原(PCNA)的表达量和凋亡率.透射电子显微镜进行RPE细胞形态学检测.结果 姜黄素24、48、72、96 h的IC50分别是29.31,17.50、13.24、10.99 μg/ml.姜黄素使RPE细胞阻滞在G0/G1期.姜黄素15 μg/ml作用24、48、72 h后,RPE细胞的PCNA表达量分别为(565.04±23.60),(473.61±36.88),(396.15±32.45),凋亡率分别为(12.83±0.13)%,(32.27±4.51)%,(56.81±8.67)%,各浓度组与对照组相比,差异均有统计学意义(P<0.05).透射电子显微镜显示RPE细胞出现凋亡特征.结论 姜黄素可以影响RPE细胞的PCNA合成,诱导其凋亡,从而有效抑制RPE细胞增生.姜黄素有望成为一种有效的防治PVR的天然药物.
目的 探討薑黃素對兔視網膜色素上皮(RPE)細胞增生的抑製作用及其作用機製.方法 選取第4代RPE細胞進行實驗,分為薑黃素組和空白對照組,薑黃素組設10、15、20 μg/ml 3箇質量濃度.噻唑藍比色(MTT)法檢測薑黃素10、15、20μg/ml分彆在24、48、72、96 h對體外培養的RPE細胞增生的抑製率.線性迴歸分析計算各時間段的半數抑製率(IC50)劑量.流式細胞儀(FMC)檢測薑黃素15 μg/ml作用72 h後對RPE細胞週期的影響,併且檢測薑黃素15μg/ml作用24、48,72 h後RPE細胞增生細胞覈抗原(PCNA)的錶達量和凋亡率.透射電子顯微鏡進行RPE細胞形態學檢測.結果 薑黃素24、48、72、96 h的IC50分彆是29.31,17.50、13.24、10.99 μg/ml.薑黃素使RPE細胞阻滯在G0/G1期.薑黃素15 μg/ml作用24、48、72 h後,RPE細胞的PCNA錶達量分彆為(565.04±23.60),(473.61±36.88),(396.15±32.45),凋亡率分彆為(12.83±0.13)%,(32.27±4.51)%,(56.81±8.67)%,各濃度組與對照組相比,差異均有統計學意義(P<0.05).透射電子顯微鏡顯示RPE細胞齣現凋亡特徵.結論 薑黃素可以影響RPE細胞的PCNA閤成,誘導其凋亡,從而有效抑製RPE細胞增生.薑黃素有望成為一種有效的防治PVR的天然藥物.
목적 탐토강황소대토시망막색소상피(RPE)세포증생적억제작용급기작용궤제.방법 선취제4대RPE세포진행실험,분위강황소조화공백대조조,강황소조설10、15、20 μg/ml 3개질량농도.새서람비색(MTT)법검측강황소10、15、20μg/ml분별재24、48、72、96 h대체외배양적RPE세포증생적억제솔.선성회귀분석계산각시간단적반수억제솔(IC50)제량.류식세포의(FMC)검측강황소15 μg/ml작용72 h후대RPE세포주기적영향,병차검측강황소15μg/ml작용24、48,72 h후RPE세포증생세포핵항원(PCNA)적표체량화조망솔.투사전자현미경진행RPE세포형태학검측.결과 강황소24、48、72、96 h적IC50분별시29.31,17.50、13.24、10.99 μg/ml.강황소사RPE세포조체재G0/G1기.강황소15 μg/ml작용24、48、72 h후,RPE세포적PCNA표체량분별위(565.04±23.60),(473.61±36.88),(396.15±32.45),조망솔분별위(12.83±0.13)%,(32.27±4.51)%,(56.81±8.67)%,각농도조여대조조상비,차이균유통계학의의(P<0.05).투사전자현미경현시RPE세포출현조망특정.결론 강황소가이영향RPE세포적PCNA합성,유도기조망,종이유효억제RPE세포증생.강황소유망성위일충유효적방치PVR적천연약물.
Objective To observe the inhibition effect of curcumin on the proliferation of rabbit retinal pigment epithelial (RPE) cells and investigate its mechanism.Methods The 4th generation of RPE cells were selected and divided into curcumin group and blank control group.The concentration of curcumin included 10,15,and 20 μg/ml.The MTT assay was used to evaluate the inhibition effect on the proliferation of RPE cells at the 24th,48th,72nd and 96th hour after cultured with curcumin (10,15,and 20 μg/ml).The IC50 value of curcumin at different time points were calculated by Linear Regression.Flow cytometry was used to detect the effect on the cell cycle at the 72nd hour after cultured with eurcumin (15 μg/ml) ;the expression and apoptosis of proliferating cell nuclear antigen (PCNA) were also determined at the 24th,48th,and 72nd hour after cultured with curcumin (15 μg/ml) respectively.The configuration of RPE cells were observed by transmission electron microscope.Results The IC50 value of curcumin at the 24th,48th,72nd and 96th hour was 29.31,17.50,13.24,and 10.99 μg/ml respectively.Cell cycel analysis indicated that cureumin blocked cells in G0/G1 phase.At the 24th,48th,and 72nd hour after cultured with curcumin (15 μg/ml),the expression of PCNA of RPE cells were 565.04±23.60,473.61± 36.88,and 396.15±32.45;the apoptosisrate were (12.83±0.13)%,(32.27±4.51)%,(56.81± 8.67)%,respectively.The differeces of curcumin groups compared with the control group were significant (P<0.05).Apoptosis of RPE cells was observed under transmission electron microscope.Conclusions Curcumin can inhibite the proliferation of RPE cells by inhibit the synthesization of PCNA and inducing the apoptosis of RPE cells.Curcumin may become a potential drug to prevent and treat PVR.